Novo Nordisk EPS
What is the EPS of Novo Nordisk?
The EPS of Novo Nordisk is 2.45
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on NYSE compared to Novo Nordisk
What does Novo Nordisk do?
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
Companies with eps similar to Novo Nordisk
- Ligand Pharmaceuticals has EPS of 2.44
- First Interstate BancSystem has EPS of 2.44
- Kerala Ayurveda has EPS of 2.44
- Danske Bank A/S has EPS of 2.44
- BOC Hong Kong () has EPS of 2.45
- Corning has EPS of 2.45
- Novo Nordisk has EPS of 2.45
- MetLife has EPS of 2.45
- International Paper has EPS of 2.45
- National Fertilizers has EPS of 2.46
- Business First Bancshares has EPS of 2.46
- China Overseas Land & Investment has EPS of 2.46
- HNI has EPS of 2.46